GPAT Return On Equity from 2010 to 2025
| GPAT Stock | 10.65 0.01 0.09% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.03066429 | Current Value 0.0291 | Quarterly Volatility 0.2006818 |
Check GP Act financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GP Act's main balance sheet or income statement drivers, such as Other Operating Expenses of 593.2 K, Ebitda of 9.1 M or Total Operating Expenses of 593.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.22. GPAT financial statements analysis is a perfect complement when working with GP Act Valuation or Volatility modules.
GPAT | Return On Equity | Build AI portfolio with GPAT Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.